plateau on retatrutide Stall? 👀 Here’s WHY! #retatrutide #glp1weightloss Retatrutide Stall? 👀 Here's WHY!

Some employers adding GLP-1 coverage due to employee demand Others removing coverage due to cost concerns Check with HR during open enrollment for 2026 changes Medicare/Medicaid Policy Changes Medicare Part D policy changes are expected mid-2026 that could expand GLP-1 coverage

Just last week, the agency issued a warning letter to Hims over advertising claims tied to compounded GLP-1s, a sign this issue is moving quickly into FDAs enforcement crosshairs

Conclusion Maximizing the benefits of GLP-1 therapies require a multidisciplinary approach that integrates evidence-based nutrition, physical activity, and proactive management of gastrointestinal side effects

: Availability : In production Alternative choices GLP-1 (7-36) amide is an incretin hormone that causes glucose dependent release of insulin by pancreatic beta cells

Paddock et al., 2007)

For many patients this helps reduce food noise, improve satiety, and make eating patterns easier to manage